In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteria

Infection ◽  
1980 ◽  
Vol 8 (S3) ◽  
pp. S261-S267 ◽  
Author(s):  
A. DeMaria ◽  
W. R. McCabe ◽  
J. O. Klein ◽  
W. R. McCabe
Keyword(s):  
In Vitro Studies ◽  
Gram Negative Bacteria ◽  
Significant Activity ◽  
Beta Lactam ◽  
Gram Negative ◽  
Beta Lactam Antibiotic ◽  
Lactam Antibiotic

scholarly journals Effects of reducing beta-lactam antibiotic pressure on intestinal colonization of antibiotic-resistant gram-negative bacteria

2009 ◽  
Vol 36 (3) ◽  
pp. 512-519 ◽  
Author(s):  
Saskia Nijssen ◽  
Ad Fluit ◽  
David van de Vijver ◽  
Janetta Top ◽  
Rob Willems ◽  
...  
Keyword(s):  
Gram Negative Bacteria ◽  
Intestinal Colonization ◽  
Beta Lactam ◽  
Antibiotic Resistant ◽  
Gram Negative ◽  
Beta Lactam Antibiotic ◽  
Lactam Antibiotic

scholarly journals DESIGN, SYNTHESIS, DOCKING STUDIES AND BIOLOGICAL EVALUATION OF 2-PHENYL-3-(SUBSTITUTED BENZO[d] THIAZOL-2-YLAMINO)-QUINAZOLINE-4(3H)-ONE DERIVATIVES AS ANTIMICROBIAL AGENTS

2018 ◽  
Vol 10 (10) ◽  
pp. 57
Author(s):  
Pooja Pisal ◽  
Meenakshi Deodhar ◽  
Amol Kale ◽  
Ganesh Nigade ◽  
Smita Pawar
Keyword(s):  
Antimicrobial Agents ◽  
Docking Studies ◽  
Biological Evaluation ◽  
Spectral Studies ◽  
Gram Negative Bacteria ◽  
Significant Activity ◽  
Fusion Reactions ◽  
Gram Positive ◽  
Gram Negative

Objective: A new series 2-phenyl-3-(substituted benzo[d] thiazol-2-ylamino)-quinazoline-4(3H)-one was prepared by the fusion method by reacting 2-phenyl benzoxazine with 2-hydrazino benzothiazole and it was evaluated for their antimicrobial activity against gram positive, gram negative bacteria and fungi.Methods: Titled compounds were synthesized by fusion reactions. These compounds were evaluated by in vitro antibacterial and antifungal activity using the minimum inhibitory concentration and zone of inhibition methods. The synthesized compounds were characterized with the help of infrared, NMR and mass spectral studies. The benzothiazole moiety and the quinazoline ring have previously shown DNA gyrase inhibition and target related antibacterial activity. Thus, molecular docking studies of synthesized compounds were carried out (PDB: 3G75) to study the possible interaction of compounds with the target. The batch grid docking was performed to determine the probable.Results: These compounds showed significant activity against gram positive and gram negative bacteria as well against the fungi. The compound A5 was found to be active against B. subtilis, P aeruginosa and C. albican at 12.5 µg/ml MIC. The compound A3 was found to be active against all microbial strains selected at 25 and 12.5 µg/ml MIC.Conclusion: Though the relationship between the activities shown by these compounds in, the antimicrobial study is still to be established, the docking studies conducted found to be consistent with antimicrobial results. Thus the results indicate that the designed structure can be a potential lead as an antimicrobial agent.

scholarly journals In vitro evaluation of BO-3482, a novel dithiocarbamate carbapenem with activity against methicillin-resistant staphylococci.

1997 ◽  
Vol 41 (10) ◽  
pp. 2282-2285 ◽  
Author(s):  
Y Adachi ◽  
K Nakamura ◽  
Y Kato ◽  
N Hazumi ◽  
T Hashizume ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
Clostridium Difficile ◽  
Proteus Mirabilis ◽  
Gram Negative Bacteria ◽  
Penicillin Binding Protein ◽  
Beta Lactam ◽  
Gram Negative ◽  
Methicillin Resistant ◽  
Beta Lactam Antibiotics

BO-3482, a dithiocarbamate carbapenem, inhibited clinical isolates of methicillin-resistant staphylococci (MRS) at 6.25 microg/ml (MIC at which 90% of isolates tested are inhibited [MIC90]), while the MIC90 of imipenem was > 100 microg/ml. BO-3482 was generally less active than imipenem against methicillin-susceptible Staphylococcus aureus, streptococci, enterococci, and gram-negative bacteria, although BO-3482 showed better activity (MIC90) than imipenem against Enterococcus faecium, Haemophilus influenzae, Proteus mirabilis, and Clostridium difficile. The affinities (50% inhibitory concentrations) of BO-3482 for penicillin-binding protein (PBP) PBP 2' of MRS and PBP 5 of E. faecium (both PBPs have low affinities for ordinary beta-lactam antibiotics) were 3.8 and 20 microg/ml, respectively, reflecting the greater activity of BO-3482 against MRS than against E. faecium.

scholarly journals Quaternary heterocyclylamino .BETA.-lactams. II. The in vitro antibacterial properties of L-640,876, a new type of .BETA.-lactam antibiotic.

1983 ◽  
Vol 36 (1) ◽  
pp. 47-53 ◽  
Author(s):  
LAWRENCE R. KOUPAL ◽  
BARBARA WEISSBERGER ◽  
DANIEL L. SHUNGU ◽  
ELLEN WEINBERG ◽  
HANS H. GADEBUSCH
Keyword(s):  
Antibacterial Properties ◽  
Beta Lactam ◽  
Beta Lactams ◽  
Beta Lactam Antibiotic ◽  
Lactam Antibiotic ◽  
New Type

scholarly journals In vitro activity of temocillin (BRL 17421), a novel beta-lactam antibiotic.

1982 ◽  
Vol 22 (4) ◽  
pp. 535-540 ◽  
Author(s):  
H W Van Landuyt ◽  
M Pyckavet ◽  
A Lambert ◽  
J Boelaert
Keyword(s):  
Vitro Activity ◽  
In Vitro Activity ◽  
Beta Lactam ◽  
Beta Lactam Antibiotic ◽  
Lactam Antibiotic
Sign in / Sign up

Export Citation Format

Share Document